Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Meera Subramaniyam"'
Autor:
Karl S. Peggs, Sarah J. Albon, Macarena Oporto Espuelas, Catherine Irving, Rachel Richardson, Joan Casanovas-Company, Rebecca Wallace, Aleks Guvenel, Sara Ghorashian, Angela Collura, Meera Subramaniyam, Barry Flutter, Bilyana Popova, Fernanda Castro, Andre Lopes, Kim Champion, Oliver Schofield, Laura Clifton-Hadley, Thomas Taylor, Maria Farrell, Stuart Adams, Kimberly C. Gilmour, Stephen Mackinnon, Eleni Tholouli, Persis J. Amrolia
Publikováno v:
Cytotherapy. 25:82-93
Delayed immune reconstitution is a major challenge after matched unrelated donor (MUD) stem cell transplant (SCT). In this randomized phase 2 multi-center trial, Adoptive Immunotherapy with CD25/71 allodepleted donor T cells to improve immunity after
Autor:
Ilaria M. Michelozzi, Eduardo Gomez-Castaneda, Ruben V. C. Pohle, Ferran Cardoso Rodriguez, Jahangir Sufi, Pau Puigdevall Costa, Meera Subramaniyam, Efstratios Kirtsios, Ayad Eddaoudi, Si Wei Wu, Aleks Guvenel, Jonathan Fisher, Sara Ghorashian, Martin A. Pule, Christopher J. Tape, Sergi Castellano, Persis J. Amrolia, Alice Giustacchini
Publikováno v:
Blood advances.
We recently described a low-affinity second-generation CD19 chimeric antigen receptor (CAR) CAT that showed enhanced expansion, cytotoxicity, and antitumor efficacy compared with the high-affinity (FMC63-based) CAR used in tisagenlecleucel, in precli
Autor:
Ilaria M. Michelozzi, Eduardo Gomez Castaneda, Ruben V.C. Pohle, Ferran Cardoso Rodriguez, Jahangir Sufi, Pau Puigdevall Costa, Meera Subramaniyam, Efstratios Kirtsios, Ayad Eddaoudi, Si Wei Wu, Aleks Guvenel, Jonathan Fisher, Sara Ghorashian, Martin A. Pule, Christopher J. Tape, Sergi Castellano, Persis J. Amrolia, Alice Giustacchini
We recently described a low-affinity second-generation CD19 chimeric antigen receptor (CAR) CAT that showed enhanced expansion, cytotoxicity, and anti-tumour efficacy compared to the high-affinity (FMC63 based) CAR used in Tisagenlecleucel, in pre-cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b79f0bbfa6bbb39f2b825d5e9d2ba484
https://doi.org/10.1101/2020.09.22.291831
https://doi.org/10.1101/2020.09.22.291831
Autor:
Ruben V.C. Pohle, Meera Subramaniyam, Sara Ghorashian, Jahangir Sufi, Martin Pule, Sergi Castellano, Ilaria M. Michelozzi, Persis Amrolia, Pau Puigdevall, Eduardo Gomez-Castaneda, Christopher J. Tape, Alice Giustacchini, Aleks Guvenel, Si Wei Wu, Ferran Cardoso Rodriguez
Publikováno v:
Blood. 136:52-53
We have recently described a low-affinity second-generation anti-CD19 Chimeric Antigen Receptor (CAR) (CAT), characterized by faster antigen dissociation rate which showed enhanced expansion, cytotoxicity and anti-tumour efficacy compared with the hi
Autor:
Karl S. Peggs, Eleni Tholouli, Persis Amrolia, Laura Clifton-Hadley, Catherine Irving, Barry Flutter, Fernanda Castro, Stuart J. Ings, Kim Champion, Joan Casanovas-Company, Aleks Guvenel, Angela Collura, Rachael Wilding, Bilyana Popova, Timothy Pulham, Kimberly Gilmour, Thomas Taylor, Oliver Schofield, Sarah J. Albon, Rebecca Wallace, Andre Lopes, Wendy Ogden, Meera Subramaniyam, Rachel Richardson, Stuart Adams, Robert Herlihy, Stephen Mackinnon, Gulrukh Ahsan, Maria Farrell, Sara Ghorashian
Publikováno v:
Blood. 134:1995-1995
Karl S Peggs and Sarah J Albon contributed equally to the work and are joint first author Introduction Alemtuzumab reduces the incidence of GVHD after unrelated donor stem cell transplant (MUD SCT) but delays immune reconstitution resulting in high m